ANAVEX LIFE SCIENCES CORP. Cash
ANAVEX LIFE SCIENCES CORP. (AVXL) had Cash of $149.16 million as of 2022-09-30, per its 10-K filed 2022-11-28.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:Cash · last filed 2022-11-28
- 2022-09-30: Cash $149.16M.
- 2021-09-30: Cash $152.11M.
- 2020-12-31: Cash $47.36M.
- 2020-09-30: Cash $29.25M.
| Period end | Cash |
|---|---|
| 2022-09-30 | $149.16M 10-K · filed 2022-11-28 |
| 2021-09-30 | $152.11M 10-K · filed 2022-11-28 |
| 2020-12-31 | $47.36M 10-Q · filed 2021-02-16 |
| 2020-09-30 | $29.25M 10-K · filed 2022-11-28 |
| 2020-06-30 | $27.62M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $26.56M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $27.46M 10-Q · filed 2021-02-16 |
| 2019-09-30 | $22.19M 10-K · filed 2022-11-28 |
| 2019-06-30 | $21.25M 10-Q · filed 2020-08-06 |
| 2019-03-31 | $19.46M 10-Q · filed 2020-05-07 |
| 2018-12-31 | $20.72M 10-Q · filed 2020-02-06 |
| 2018-09-30 | $22.93M 10-K · filed 2020-12-28 |
| 2018-06-30 | $25.83M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $25.66M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $28.05M 10-Q · filed 2018-02-07 |
| 2017-09-30 | $27.44M 10-K · filed 2019-12-16 |
| 2017-06-30 | $24.79M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $23.35M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $21.16M 10-Q · filed 2018-02-07 |
| 2016-09-30 | $9.19M 10-K · filed 2019-01-25 |
| 2016-06-30 | $9.73M 10-Q · filed 2017-08-07 |
| 2016-03-31 | $11.95M 10-Q · filed 2017-05-10 |
| 2015-12-31 | $13.85M 10-Q · filed 2017-02-07 |
| 2015-09-30 | $15.29M 10-K · filed 2019-01-25 |
| 2015-06-30 | $7.96M 10-Q · filed 2016-08-11 |
| 2015-03-31 | $6.31M 10-Q · filed 2016-05-11 |
| 2014-12-31 | $6.98M 10-Q · filed 2016-02-08 |
| 2014-09-30 | $7.26M 10-K · filed 2017-12-11 |
| 2014-06-30 | $8.18M 10-Q · filed 2015-08-14 |
| 2014-03-31 | $9.19M 10-Q · filed 2015-05-14 |
| 2013-12-31 | $95.93K 10-Q · filed 2015-02-17 |
| 2013-09-30 | $345.07K 10-K · filed 2016-12-14 |
| 2013-06-30 | $1.65K 10-Q · filed 2014-08-13 |
| 2013-03-31 | $487.00 10-Q/A · filed 2014-05-30 |
| 2012-12-31 | $79.79K 10-Q · filed 2014-02-14 |
| 2012-09-30 | $11.36K 10-K · filed 2014-12-29 |
| 2012-06-30 | $18.20K 10-Q · filed 2013-08-14 |
| 2012-03-31 | $178.65K 10-Q · filed 2013-05-17 |
| 2011-12-31 | $9.08K 10-Q · filed 2013-02-14 |
| 2011-09-30 | $134.70K 10-K · filed 2013-12-30 |
| 2011-06-30 | $1.22M 10-Q · filed 2012-08-17 |
| 2011-03-31 | $3.64K 10-Q · filed 2012-05-15 |
| 2010-12-31 | $423.78K 10-Q · filed 2012-02-14 |
| 2010-09-30 | $264.67K 10-K · filed 2012-12-31 |
| 2010-06-30 | $1.46M 10-Q · filed 2011-08-12 |
| 2009-09-30 | $350.99K 10-K · filed 2011-12-22 |
| 2004-01-22 | $0.00 10-Q/A · filed 2014-05-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |